These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8384912)

  • 41. Anti-hepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins.
    Marson P; Ostuni PA; Vicarioto M; Ongaro G; Gambari PF
    Clin Exp Rheumatol; 1991; 9(6):661-2. PubMed ID: 1662569
    [No Abstract]   [Full Text] [Related]  

  • 42. Two cases of porphyria cutanea tarda associated with chronic hepatitis positive for the antibody against hepatitis C virus.
    Kanno A; Amakasu H; Torinuki W; Yamamoto T; Ishii M; Numata N; Ohori H
    Tohoku J Exp Med; 1994 Jan; 172(1):83-90. PubMed ID: 7913558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-HCV antibodies against the structural and nonstructural antigens of hepatitis C in people seropositive in the second generation test].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(3):159-65. PubMed ID: 1284256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
    Abb J
    Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevalence of HBsAg, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter].
    Gonçales Júnior FL; Boccato RS; Pedro Rde J; Papaiordanou PM; de Souza CA; Gonçales NS; Pellegrino Júnior J
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):45-51. PubMed ID: 7506445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical significance and the problems of HCV antibody].
    Yano M
    Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
    Hayashi S; Tanaka S; Wakashima M; Saeki S; Tanaka T; Shibayama T; Otake H; Hattori N
    Nihon Rinsho; 1991 Feb; 49(2):432-8. PubMed ID: 1849205
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease.
    Paydas S; Aksu HS; Paydas S; Burgut R; Sagliker Y
    Br J Clin Pract; 1994; 48(1):25-6. PubMed ID: 8179977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts].
    Laskus T; Radkowski M; Werezyńska T; Horban A; Lupa E; Cianciara J; Slusarczyk J
    Pol Arch Med Wewn; 1992 Jan; 87(1):8-13. PubMed ID: 1322535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second-generation RIBA to confirm diagnosis of HCV infection.
    Lancet; 1991 Apr; 337(8746):912-3. PubMed ID: 1672986
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
    Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
    Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The study of HCV antibody and serologic tests for syphilis in Thai patients with gynecologic disorders.
    Roongpisuthipong A; Suphanit I; Yamaguchi K; Miyazaki K; Kiyokawa T; Takatsuki K; Nakamitsu M; Yoshiki K
    Asian Pac J Allergy Immunol; 1993 Dec; 11(2):135-9. PubMed ID: 7521643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Courouce AM; Bouchardeau F; Girault A; Le Marrec N
    Lancet; 1994 Apr; 343(8901):853-4. PubMed ID: 7511195
    [No Abstract]   [Full Text] [Related]  

  • 58. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
    Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
    J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
    Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
    Haematologica; 1992; 77(2):188. PubMed ID: 1328000
    [No Abstract]   [Full Text] [Related]  

  • 60. High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease.
    Buscarini E; Tanzi E; Zanetti AR; Savi E; Sbolli G; Civardi G; Di Stasi M; Fornari F; Buscarini L
    Scand J Gastroenterol; 1993 Apr; 28(4):343-6. PubMed ID: 7683824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.